Newsfeeds Archive - Spark Newswire

1 minute read

M&A
News

Jounce Therapeutics To End Proposed Business Combination With Redx Pharma Following Takeover Offer From Concentra Biosciences

April 3, 3:42 AM

Jounce Therapeutics, Inc. ("Jounce" or the "Company") and Redx Pharma plc ("Redx") have agreed to terminate their proposed business combination following the decision by Jounce's Board

JNCE

3 minute read

Nasdaq Edges Lower; Unity Biotechnology Shares Plummet

By Lisa Levin

March 27, 2:37 PM

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading lower on Monday. The Dow traded up 0.91% to 32,530.40 while the NASDAQ fell 0.09% to 11,813.90. The S&P 500, also rose, gaining, 0.55% to 3,992.68.

CRKN

3 minute read

Movers

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

March 27, 1:31 PM

Gainers Alimera Sciences (NASDAQ:ALIM) shares moved upwards by 33.2% to $1.8 during Monday’s regular session. As of 13:30…

ALIM

4 minute read

Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

March 27, 1:22 PM

Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 59.6% to $0.2513. Crown Electrokinetics said it has entered into an agreement with a leading infrastructure solutions provider.

BCLI

3 minute read

Gold Drops Over 1%; First Citizens BancShares Shares Spike Higher

By Lisa Levin

March 27, 12:15 PM

U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 100 points on Monday. The Dow traded up 0.42% to 32,372.55 while the NASDAQ rose 0.01% to 11,825.46. The S&P 500, also rose, gaining, 0.24% to 3,980.71.

CRKN

2 minute read

Jounce Therapeutics Enters Into Agreement To Be Acquired By Concentra Biosciences For $1.85 In Cash Per Share Plus Contingent Value Rights

By Happy Mohamed

March 27, 9:01 AM

Jounce Therapeutics, Inc. (NASDAQ:JNCE) ("Jounce" or the "Company"), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers,

JNCE

3 minute read

Benzinga’s ‘Stock Whisper’ Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet

By Chris Katje

March 18, 4:36 PM

Investors are on the hunt for undervalued, underfollowed and emerging stocks when it comes to spotting opportunities. Retail traders have countless methods at their disposal to uncover new information.

AMD

3 minute read

S&P 500 Down Over 1%; ThermoGenesis Shares Spike Higher

By Lisa Levin

March 15, 3:11 PM

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 400 points on Wednesday. The Dow traded down 1.32% to 31,732.39 while the NASDAQ fell 0.24% to 11,400.70. The S&P 500, also fell, dropping, 1.11% to 3,875.80.

APEI

3 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

March 15, 1:30 PM

Gainers ThermoGenesis Holdings (NASDAQ:THMO) shares rose 78.7% to $3.77 during Wednesday’s regular session. As of 13:30 EST, this…

BLCM

3 minute read

Why American Public Education Shares Are Trading Lower By Around 49%? Here Are Other Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

March 15, 1:20 PM

Gainers ThermoGenesis Holdings, Inc. (NASDAQ: THMO) shares jumped 80% to $3.7820 after the company announced the roll out of ReadyStart cGMP Suites for early-stage cell and gene-therapy companies.

$APE